6-(trifluoromethyl)-3,4-dihydro-2H-benzo[e][1,2,4]thiadiazine-7-sulfonamide1,1-dioxide-13CD2;3,4-Dihydro-6-(trifluoromethyl)-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-Dioxide-13C-d2;Bristab-13C-d2; Bristurin-13C-d2; Dihydroflumethiazide-13C-d2; Diucardin-13C-d2; Elodrine-13C-d2; Finuret-13C-d2; Flutizide-13C-d2; Glomerulin-13C-d2; Hidroalogen-13C-d2; Leodrine-13C-d2; Saluron-13C-d2; Vergonil-13C-d2;Hydroflumethiazide-13C-d2;Hydroflumethiazide-13C-d2
Hydroflumethiazide-13C-d2 is a fully characterized chemical compound used as a reference standard of API Hydroflumethiazide. The standard offered is compliant with regulatory guidelines. Hydroflumethiazide-13C-d2 is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS -
